News Ex dividend NOK 1.25 today Staff June 4, 2025 The shares in Vistin Pharma ASA (VISTN) will be traded ex dividend NOK 1.25 as from today, 04.06.2025. Iframe sync Post navigation Previous: Roche’s Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)Next: Ose Immunotherapeutics : Documents made available to the shareholders for the combined general meeting of June 25th, 2025 More Stories Cancer Diagnostics DNA Medicare News Patient Care Pharmaceutical Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting Staff December 6, 2025 Cancer Clinical Trial News Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition Staff December 6, 2025 Cancer Clinical Trial News Pharmaceutical Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company’s RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma Staff December 6, 2025
